A clinical study of MK-3475A to treat newly-diagnosed metastatic non-small cell lung cancer (MK-3475A-F84)

Trial Identifier: 3475A-F84
Sponsor: MSD
Start Date: November 2024
Primary Completion Date: June 2026
Study Completion Date: February 2030
Condition: Lung Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
Protocol Plain Language Summary

Trial Locations

Country Location
Korea, Republic of, Pusan-Kwangyokshi Pusan Kwangyokshi, Pusan-Kwangyokshi, Korea, Republic of, 49241
Korea, Republic of, Seoul Seoul, Korea, Republic of, 8308
Korea, Republic of, Taejon-Kwangyokshi Daejeon, Taejon-Kwangyokshi, Korea, Republic of, 35015
Poland, Mazowieckie Siedlce, Mazowieckie, Poland, 08-110
Romania, Cluj Cluj, Romania, 400015
Romania, Cluj Floresti, Cluj, Romania, 407280
Spain, Huelva Huelva, Spain, 21005